Evidence map›Paper›PMID 36777784›Full record

ArticleFrontiers in public health2022

Understanding COVID-19 vaccine hesitancy: A cross-sectional study in Malang District, Indonesia.

Sujarwoto, Asri Maharani, Holipah, Sri Andarini, Rindi Ardika Melsalasa Saputri, Eduwin Pakpahan, Delvac Oceandy, Gindo Tampubolon

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

SujarwotoDepartment of Public Administration, Faculty of Administrative Science, Brawijaya University, Malang, Indonesia.
Asri MaharaniDepartment of Nursing, Faculty of Health and Education, Manchester Metropolitan University, Manchester, United Kingdom.
HolipahDepartment of Public Health, Faculty of Medicine, Brawijaya University, Malang, Indonesia.
Sri AndariniDepartment of Public Health, Faculty of Medicine, Brawijaya University, Malang, Indonesia.
Rindi Ardika Melsalasa SaputriDepartment of Public Administration, Faculty of Administrative Science, Brawijaya University, Malang, Indonesia.
Eduwin PakpahanDepartment of Mathematics, Physics, and Electrical Engineering, Northumbria University, Newcastle upon Tyne, United Kingdom.
Delvac OceandyDivision of Cardiovascular Sciences, The University of Manchester, Manchester, United Kingdom.
Gindo TampubolonGlobal Health at the Global Development Institute, The University of Manchester, Manchester, United Kingdom.
University of Brawijaya · IDManchester Metropolitan University · GBNorthumbria University · GBThe George Institute for Global Health · GBUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Vaccine hesitancy could undermine efforts to reduce incidence of coronavirus disease 2019 (COVID-19). Understanding COVID-19 vaccine hesitancy is crucial to tailoring strategies to increase vaccination acceptance. This study aims to investigate the prevalence of and the reasons for COVID-19 vaccine hesitancy in Malang District, Indonesia. Methods: Data come from a cross-sectional study among individuals aged 17-85 years old (N = 3,014). Multivariate ordered logistic regression was used to identify factors associated with postponing or refusing COVID-19 vaccines. The Oxford COVID-19 vaccine hesitancy scale was used to measure vaccine hesitancy. A wide range of reasons for hesitancy, including coronavirus vaccine confidence and complacency, vaccination knowledge, trust and attitude in health workers and health providers, coronavirus conspiracy, anger reaction and need for chaos, populist views, lifestyle, and religious influence, was examined. Results and discussion: The results show that 60.2% of the respondents were hesitant to receive the COVID-19 vaccine. Low confidence and complacency beliefs about the vaccine (OR = 1.229, 95% CI = 1.195-1.264) and more general sources of mistrust within the community, particularly regarding health providers (OR = 1.064, 95% CI = 1.026-1.102) and vaccine developers (OR = 1.054, 95% CI = 1.027-1.082), are associated with higher levels of COVID-19 vaccine hesitancy. Vaccine hesitancy is also associated with anger reactions (OR = 1.019, 95% CI = 0.998-1.040), need for chaos (OR = 1.044, 95% CI = 1.022-1.067), and populist views (OR = 1.028, 95% CI = 1.00-1.056). The findings were adjusted for socio-demographic factors, including age, sex, education, marital status, working status, type of family, household income, religious beliefs, and residency. The results suggest the need for an effective health promotion program to improve community knowledge of the COVID-19 vaccine, while effective strategies to tackle "infodemics" are needed to address hesitancy during a new vaccine introduction program.

Indexed as

COVID-19COVID-19 VaccinesAdolescentAdultAgedAged, 80 and overCross-Sectional StudiesEducational StatusHumansIndonesiaMiddle AgedYoung AdultCOVID-19 Vaccinesconfidence and complacency beliefscoronaviruscross-sectional studyrural Indonesiavaccine hesitancy

Identifiers

PMID36777784
PMCPMC9909106
OpenAlexW4318050002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.